Metabolic syndrome X

Search with Google Search with Bing
Information
Disease name
Metabolic syndrome X
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02356952 Completed N/A Effect of a Low Glycemic Index on Metabolic Syndrome September 2014 August 2015
NCT00005365 Completed Central Obesity and Disease Risk in Japanese Americans February 1993 January 1998
NCT00005374 Completed Genetics of the Metabolic Syndrome in Japanese Americans January 1994 May 2004
NCT00049881 Completed Genetic Determinants:Low HDL, High Triglycerides, Obesity April 2002 March 2004
NCT00073775 Completed Epidemiology of Stress and the Metabolic Syndrome September 2003 August 2008
NCT00074451 Completed Genomewide Search for Loci Underlying Metabolic Syndrome September 2003 August 2008
NCT00101517 Completed Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease September 2004 December 2009
NCT00106457 Completed 20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA February 2005 November 2008
NCT00108329 Completed N/A Weight Loss in Diabetic, Older Obese Adults April 2003 March 2006
NCT00111956 Completed Phase 2/Phase 3 Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome April 2004 May 2005
NCT00115232 Completed Inflammatory Profiles of Children at High Risk for Atherosclerosis July 2004 March 2007
NCT00119795 Completed N/A Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese August 2005 April 2011
NCT00128154 Completed N/A Chromium Picolinate for the Treatment of Metabolic Syndrome January 2004 December 2005
NCT00129792 Completed N/A Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome January 2005 April 2014
NCT00130286 Completed Phase 1/Phase 2 Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance March 2005 August 2010
NCT00140816 Completed N/A Dairy Products and Metabolic Effects (Norwegian Part) September 2005 November 2008
NCT00147264 Completed Phase 3 Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial April 2004 November 2006
NCT02288572 Completed Phase 2 Probiotic Bacteria in Prevention of the Metabolic Syndrome May 2013 May 2014
NCT02298725 Completed N/A Individual Metabolism and Physiology Signature Study December 16, 2014 March 30, 2017
NCT02337933 Completed Phase 2 Effect of Ursolic Acid Administration on Insulin Sensitivity and Metabolic Syndrome September 2014 September 2015
NCT02347007 Completed N/A Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults October 2014 March 2019
NCT02354339 Completed N/A Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity January 2015 June 2016
NCT00005314 Completed Behavioral Factors in Coronary Heart Disease July 1986 December 2008
NCT02402985 Completed N/A Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics September 2013 March 2015
NCT02407522 Completed Phase 2/Phase 3 The Improvements of Dietary Supplement of Black Rice on Metabolic Syndrome June 2014 December 2014
NCT02459691 Completed N/A Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos) September 2014 May 2019
NCT02495961 Completed Study of Chronic Degenerative Diseases June 2015 February 2016
NCT02531334 Completed N/A Effects of TA-65, a Telomerase Activator on Metabolic Syndrome August 2015 June 2018
NCT02542176 Completed N/A Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome October 2015 March 2018
NCT02605655 Completed Early Phase 1 Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome June 2014 April 2015
NCT02637115 Completed N/A Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome December 2015 February 20, 2018
NCT02649348 Completed N/A Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome September 2015 February 2018
NCT02672592 Completed Phase 3 Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome January 2016 June 2017
NCT02728570 Completed N/A Effect of Dietary Flavonoids on Intestinal Microbiota, Intestinal Inflammation and Metabolic Syndrome November 2013 October 2015
NCT02753231 Completed N/A Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent January 2017 December 2017
NCT02767869 Completed Phase 2 Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity January 2015 February 2017
NCT02832453 Completed N/A Metabolic Risk Management, Physical Exercise and Lifestyle Counselling in Low-active Adults; Controlled Randomized Trial February 2016 December 31, 2017
NCT02850562 Completed N/A Diet and Exercise Interventions to Increase Muscle Strength and Function July 2016 April 1, 2017
NCT02905448 Completed N/A Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases January 2016 July 2017
NCT02918422 Completed N/A Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption September 2015 December 2018
NCT02936687 Completed Phase 1 Mechanisms of Cerebrovascular Control January 31, 2017 September 30, 2021
NCT02949622 Completed N/A Multimodal Intervention Program for Patients With Metabolic Syndrome February 2013 October 2016
NCT02969720 Completed N/A Therapeutic Efficacy of Phytosterols on Metabolic Syndrome January 8, 2018 November 27, 2018
NCT02972567 Completed N/A Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease May 2016 December 2017
NCT02982967 Completed N/A Recreational Physical Activity and Cardiometabolic Profile April 2013 June 2015
NCT02983188 Completed Phase 2/Phase 3 Berberine as Adjuvant Treatment for Schizophrenia Patients April 25, 2018 January 4, 2021
NCT03012516 Completed N/A Physical Activity on Prescription in Patients With Metabolic Risk Factors. January 2010 September 15, 2020
NCT03019796 Completed Early Phase 1 Exercise Training Effects on Metabolic Syndrome: Interactions With Medication July 2015 August 2020
NCT03119493 Completed N/A Periodized Aerobic Interval Training in Metabolic Syndrome June 1, 2015 December 1, 2016
NCT03309761 Completed Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69 December 11, 2017 July 15, 2019
NCT03310359 Completed N/A Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects July 2016 December 31, 2022
NCT03358745 Completed N/A Impact of Meal Order on Postprandial Cardiometabolic Risk Markers June 1, 2016 December 1, 2018
NCT03586011 Completed Predictors of Increased Physical Activity in Patients Receiving Physical Activity on Prescription January 1, 2010 May 2, 2019
NCT03856606 Completed N/A The Effects of Interrupting Prolonged Sitting With Intermittent Exercise on Postprandial Lipemia February 20, 2018 July 8, 2018
NCT06379204 Completed N/A A Study on the Intervention of Metabolic Syndrome Patients With Exercise Prescription Based on Ventilatory Threshold Using Cardiopulmonary Exercise Test November 4, 2022 September 19, 2023
NCT00166036 Completed Phase 2 Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells September 2004 April 2009
NCT00175071 Completed N/A Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers March 2004 July 2012
NCT00175084 Completed N/A Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers October 2004 December 2012
NCT00184899 Completed N/A The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids August 2005 August 2006
NCT00194428 Completed Phase 1/Phase 2 Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons February 2005 October 2009
NCT00200993 Completed Phase 2 Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) September 1998 April 2009
NCT00205504 Completed Phase 4 Oral Contraceptives in the Metabolic Syndrome June 2005 June 2009
NCT00224822 Completed Phase 4 The Effects of Aripiprazole on Patients With Metabolic Syndrome March 2004 March 2007
NCT00242814 Completed Phase 4 Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities November 3, 2005
NCT00264667 Completed Phase 2 Study In Patients With Dyslipidaemia December 2005 June 2007
NCT00272311 Completed Phase 4 Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome October 2006 January 2009
NCT00275145 Completed Phase 2 Effects of Resistance and Aerobic Exercise on Cardiovascular Health May 2004 December 2008
NCT00293852 Completed N/A Collaborative Care for Heart Failure Patients With the Metabolic Syndrome February 2006 December 10, 2015
NCT00296803 Completed Phase 4 PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome November 2005 August 2006
NCT00297154 Completed N/A The Effect of Diet and Exercise in Heart Failure March 2005 June 2009
NCT00298428 Completed N/A Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE) May 2006 December 2008
NCT00304993 Completed Phase 4 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia January 2001 February 2005
NCT00318734 Completed Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults May 2006 April 2011
NCT00325936 Completed Phase 4 The Effects of Cilnidipine on Metabolic Syndrome Improvement July 2005 June 2007
NCT00327002 Completed Phase 2 A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism January 2006 November 2006
NCT00327054 Completed Phase 1/Phase 2 Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia February 2006 March 2007
NCT00338949 Completed Phase 4 Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes June 2006 December 2009
NCT00344903 Completed Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort September 2007 December 2009
NCT00362128 Completed Cardiovascular Disease Risk Factors in Chinese American Immigrants January 2007 October 2009
NCT00362908 Completed N/A Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome September 2006 June 2010
NCT00363181 Completed Side Effects of Antipsychotic Medications April 2006 December 2011
NCT00395486 Completed Phase 4 ROMEO (Rosuvastatin in Metabolic syndrOme) September 2006 June 2008
NCT00399360 Completed N/A Lifestyle Modification and Metformin Use in the Treatment of HIV December 2006 June 2012
NCT00400231 Completed Phase 2 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study August 2005 March 2008
NCT00401336 Completed N/A Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging November 2006 March 2013
NCT00405197 Completed N/A MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study November 2006 April 2007
NCT00422630 Completed N/A The Metabolic Effects of Different Weight Loss Diets October 2007 February 2010
NCT00448630 Completed An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics October 23, 2007 July 30, 2008
NCT00455325 Completed Phase 2 Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) September 2004 March 2012
NCT00455403 Completed N/A Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) April 2006 December 2009
NCT00470262 Completed N/A Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation January 2007 June 2014
NCT00489333 Completed N/A ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome May 2006 September 2006
NCT00515021 Completed Phase 4 Diurnal Variation of Plasminogen Activator Inhibitor-1 April 2007 April 2010
NCT00515476 Completed N/A Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Metabolic Syndrome(HERMET-Study) June 2007 December 2008
NCT00523562 Completed N/A Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity July 2006 January 2009
NCT00545805 Completed Phase 2/Phase 3 Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity October 2005 June 2009
NCT00558740 Completed Effects of Dietary Proteins on Hepatic Lipid Metabolism January 2009 April 2009
NCT00561626 Completed N/A Effects of High-fat and Low-fat Diet on the Gut January 2008 December 2008
NCT00613314 Completed Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen June 2007
NCT00671515 Completed Phase 2 Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome April 2008 November 2011
NCT00675857 Completed Phase 2 A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes April 2008 May 2010
NCT00695825 Completed N/A Effects the Glycemic Index on Metabolic Risk Markers April 1, 2006 December 31, 2008
NCT00733772 Completed Phase 2/Phase 3 Flaxseed Intervention on Metabolic Syndrome March 2009 December 2009
NCT00742742 Completed Phase 2/Phase 3 Walnut Intervention on Metabolic Syndrome (WIMS) March 2009 December 2009
NCT00864461 Completed Frequency of Metabolic Syndrome in Down Syndrome Patients September 1, 2009 March 31, 2010
NCT00946868 Completed Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication May 2009 July 2009
NCT00954824 Completed N/A Inflammation and the Metabolic Syndrome in Humans August 2003 November 2007
NCT00956189 Completed N/A Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome November 2009 October 2012
NCT00957294 Completed Metabolic Syndrome in Patients With First-episode Schizophrenia August 2009 April 2013
NCT01004120 Completed Phase 1/Phase 2 Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults October 2009 December 2012
NCT01022411 Completed Phase 2/Phase 3 Brown Rice Intervention on Metabolic Syndrome (BRIMS) October 2009 October 2010
NCT01044680 Completed Phase 2/Phase 3 Effects of NUTRIOSE®FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweight Adult Men October 2006 February 2007
NCT01145066 Completed Phase 2 Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects May 2009 March 2011
NCT01173380 Completed N/A Soy Nut Study on Markers of Health August 2010 September 2012
NCT01241474 Completed N/A Effect of Fish Oil on Insulin Sensitivity February 2009 June 2012
NCT01428791 Completed N/A Reducing Disparities in Late Life Depression and Metabolic Syndrome March 2011 December 16, 2014
NCT01457794 Completed N/A OPUS School Meal Study May 2011 June 2012
NCT01465620 Completed Phase 3 Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study November 2011 June 2018
NCT01548300 Completed Environmental Triggers Of Cardiometabolic Disease February 2011 December 2014
NCT01577277 Completed OPUS School Meal Study - Cross Sectional Analyses From Baseline Investigations May 2011 December 2011
NCT01681173 Completed N/A OPTIFIT-Optimal Fiber Trial for Diabetes Prevention May 2010 December 2014
NCT01694056 Completed N/A Soy Protein Intake and the Metabolic Syndrome September 2012 December 2012
NCT01705210 Completed Functional MRI Biomarkers of Cognitive Decrements in Diabetes May 2012 April 2015
NCT01739127 Completed Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI November 2012 February 2016
NCT01794429 Completed Phase 3 Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue February 2013 June 2015
NCT01806142 Completed N/A Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome February 2011 February 2013
NCT01806506 Completed N/A Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity November 2008 November 2013
NCT01829945 Completed Study of the Relationships Between Apolipoprotein B-48 Kinetics and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With the Metabolic Syndrome (SMB48) October 2009 February 2011
NCT01849068 Completed Phase 3 Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study June 2013 February 2016
NCT01913756 Completed N/A Dairy Products and Metabolic Syndrome April 2013 July 2013
NCT01944124 Completed N/A Exercise and Technology to Reduce Risk in a Rural Population With Metabolic Syndrome November 2009 December 2011
NCT02017561 Completed Phase 2 Metformin in the Diastolic Dysfunction of Metabolic Syndrome January 2014 December 2019
NCT02035592 Completed N/A The Health Effects of Blueberry Anthocyanins in Metabolic Syndrome (the CIRCLES-study) January 2014 November 7, 2016
NCT02042274 Completed N/A Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health October 2012 February 2015
NCT02113241 Completed Phase 2/Phase 3 Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion April 2014 May 2015
NCT02114892 Completed Phase 2 Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion April 2012 September 2013
NCT02151227 Completed Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis June 2014 December 2014
NCT02202863 Completed N/A Effects of Wine Grape Pomace Flour Used as a Dietary Supplement on Metabolic Syndrome Components April 2013 September 2013
NCT02278757 Completed N/A Effect of Two Diets With Different Content of Protein on Weight Loss in Adults With Metabolic Syndrome January 2014 March 2015
NCT03701425 Enrolling by invitation N/A Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population June 1, 2017 December 1, 2024
NCT02420470 Recruiting The Early Warning System for the Diabetic Encephalopathy April 2015 December 2026
NCT02479113 Recruiting Maternal Hypertriglyceridaemia Study March 2014 December 2024
NCT06394934 Recruiting Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients January 9, 2024 December 31, 2029
NCT00243984 Suspended Phase 3 Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome March 2005 November 2007
NCT00614757 Suspended N/A Insulin Resistance Study May 2005 December 2013
NCT00608465 Terminated Phase 4 Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity May 2006 May 2011
NCT00663104 Terminated Phase 3 Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause April 2008 November 2009
NCT02174783 Terminated N/A Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients June 2014 April 2015
NCT01351753 Terminated Phase 2 Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity March 2011 January 9, 2014
NCT00225355 Terminated Phase 4 Rosiglitazone Versus Placebo in Chronic Stable Angina February 2006 November 2006
NCT00228176 Terminated Phase 3 Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant August 2005 April 2009
NCT00269646 Unknown status N/A Comparison of Two Different Diets on Health Outcomes November 2004 August 2009
NCT02480673 Unknown status N/A EFFECT OF Salvia Hispanica l. (CHIA) IN THE BIOCHEMICAL METABOLIC SYNDROME COMPONENTS June 2015 May 2016
NCT03417128 Unknown status N/A Nutrition and Lifestyle Behaviour Peer Support Program Among Malaysian Adults With Metabolic Syndrome (PERSUADE) March 15, 2016 March 2021
NCT02696304 Unknown status N/A The Metabolic Syndrome Among Leukemia Survivors: Physiopathological Analysis May 2015 December 2016
NCT02702375 Unknown status Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases September 2015 September 2018
NCT00315770 Unknown status Phase 1 Health of Young European Families and Fish Consumption January 2004 April 2020
NCT00566566 Unknown status Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors January 2008 December 2008
NCT00573950 Unknown status Phase 4 Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness December 2007 December 2008
NCT00350194 Unknown status Early Phase 1 The Effects of Omega-3 Fatty Acids on Metabolic Syndrome October 2006 June 2012
NCT00632879 Unknown status The Study of Metabolic Syndrome in Hemodialysis Patients March 2007 March 2008
NCT02066012 Unknown status MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload) February 2014 October 2014
NCT00399997 Unknown status Phase 2/Phase 3 Evaluation of Effect of Exercise on Prescription January 2005 August 2007
NCT00172614 Unknown status The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance December 2004
NCT00172796 Unknown status Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes April 2005
NCT00716300 Unknown status High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome July 2008 December 2009
NCT02615444 Unknown status N/A The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors October 2015 December 2016
NCT00177892 Unknown status N/A Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress September 2003 August 2008
NCT02958579 Unknown status a Population Based Study on Metabolic Syndrome Complications, and Mortality January 2005 January 2020
NCT00408824 Unknown status Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study) September 2006
NCT02130336 Unknown status N/A The Effects of High-intensity Aerobic Training in Patients With Metabolic Syndrome November 2012 July 2015
NCT02136472 Unknown status Female Subfertility: a Metabolic and Vascular Profile April 2014 May 2016
NCT01752465 Unknown status N/A Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders? January 2016 September 2016
NCT00163943 Unknown status N/A Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions April 2005 December 2007
NCT02606812 Unknown status N/A Effect of Food Consumption on microRNA Related to Metabolic Syndrome March 2017 April 2018
NCT02365129 Unknown status N/A Activating Brown Adipose Tissue Through Exercise February 2015 July 2017
NCT00536211 Withdrawn N/A Physical Inactivity and Insulin Resistance in Skeletal Muscle. June 2009 December 2011